NCT06897566View on ClinicalTrials.gov

Barriers to Optimal LDL-C Targets in Patients With Atherosclerotic Cardiovascular Disease

Not yet recruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

May 21, 2025

Primary Completion Date

July 1, 2025

Study Completion Date

July 30, 2025

Conditions
Coronary Artery DiseaseStatin Adverse ReactionLDL Level
Interventions
DIAGNOSTIC_TEST

Fasting lipid profile

Recruited patients will be requested to provide data from their most recent fasting lipid profile

Trial Locations (1)

Unknown

Faculty of Medicine, Cairo University, Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT06897566 - Barriers to Optimal LDL-C Targets in Patients With Atherosclerotic Cardiovascular Disease | Biotech Hunter | Biotech Hunter